147 related articles for article (PubMed ID: 37593995)
1. Updated evidence of beneficial effect of LDL apheresis for refractory nephrotic syndrome due to a variety of causative diseases for nationwide and global approval.
Muso E; Kakita H; Suzuki H; Tsukamoto T
Ther Apher Dial; 2023 Dec; 27(6):987-999. PubMed ID: 37593995
[TBL] [Abstract][Full Text] [Related]
2. An update on LDL apheresis for nephrotic syndrome.
Raina R; Krishnappa V
Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
[TBL] [Abstract][Full Text] [Related]
5. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
[TBL] [Abstract][Full Text] [Related]
6. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K
Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
Muso E
Clin Exp Nephrol; 2014 Apr; 18(2):286-90. PubMed ID: 24535024
[TBL] [Abstract][Full Text] [Related]
8. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Shah L; Hooper DK; Okamura D; Wallace D; Moodalbail D; Gluck C; Koziell A; Zaritsky JJ
Pediatr Nephrol; 2019 Nov; 34(11):2343-2350. PubMed ID: 31250206
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
Muso E; Mune M; Yorioka N; Nishizawa Y; Hirano T; Hattori M; Sugiyama S; Watanabe T; Kimura K; Yokoyama H; Sato H; Saito T
Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients.
Al-Mousily MF; Nicoara O; Selewski DT; Nadig S; Twombley K
J Clin Apher; 2022 Aug; 37(4):411-414. PubMed ID: 35238425
[TBL] [Abstract][Full Text] [Related]
11. [A case of focal segmental glomerulosclerosis(FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis].
Takaki A; Nakatsuka A; Satou C; Iwata Y; Ikeda H; Fukushima M
Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):806-12. PubMed ID: 12607970
[TBL] [Abstract][Full Text] [Related]
12. Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.
Al-Mousily M; Nicoara O; Selewski DT; Twombley K
Pediatr Nephrol; 2022 Mar; 37(3):585-592. PubMed ID: 34453196
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
14. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
Araki H; Ono S; Nishizawa Y; Deji N; Nakazawa J; Morita Y; Kume S; Chin-Kanasaki M; Isshiki K; Araki S; Arimura T; Maegawa H; Uzu T
Intern Med; 2015; 54(17):2213-7. PubMed ID: 26328649
[TBL] [Abstract][Full Text] [Related]
15. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
[No Abstract] [Full Text] [Related]
16. [LDL-apheresis for refractory nephrotic syndrome].
Muso E
Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
[No Abstract] [Full Text] [Related]
17. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
[TBL] [Abstract][Full Text] [Related]
18. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
[TBL] [Abstract][Full Text] [Related]
19. Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis.
Shima H; Doi T; Okamoto T; Higashiguchi Y; Harada M; Inoue T; Tashiro M; Wariishi S; Takamatsu N; Kawahara K; Okada K; Minakuchi J
Intern Med; 2022 Jun; 61(12):1863-1867. PubMed ID: 34803098
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.
Hattori M; Ito K; Kawaguchi H; Tanaka T; Kubota R; Khono M
Pediatr Nephrol; 1993 Apr; 7(2):196-8. PubMed ID: 8476719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
